FDA.reportPublic FDA data

rucaparib (as rucaparib camsylate) 200 MG Oral Tablet

RxCUI
1862593
RxNorm name
rucaparib (as rucaparib camsylate) 200 MG Oral Tablet
Display name
rucaparib (as rucaparib camsylate) 200 MG Oral Tablet
Full name
rucaparib (as rucaparib camsylate) 200 MG Oral Tablet
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:45

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
0295d202-1cfe-7659-e063-6294a90a476erucaparib 200 MG Oral Tablet [PSN] · rucaparib 200 MG Oral Tablet [SCD] · rucaparib (as rucaparib camsylate) 200 MG Oral Tablet [SY]319These highlights do not include all the information needed to use RUBRACA safely and effectively. See full prescribing information for RUBRACA. RUBRACA ® (rucaparib) tablets, for oral use Initial U.S. Approval: 201620251231